Search Results for: PFE
Pfizer Inc. (NYSE: PFE) has given some of its basic data points for its analyst meeting today. For starters, the company has reaffirmed its guidance for 2008 that it previously offered. ...
Published:
Last Updated:
Drug maker Pfizer Inc. (NYSE: PFE) has filed a Form S-1 with the SEC for an initial public offering of the company’s animal health unit into a company to be called Zoetis Inc. Pfizer expects to...
Published:
Every time Wall St. turns around, Pfizer has something new, and not necessarily good, going on. The turmoil at the company cost the CEO his job. The company is now going through a restructuring that...
Published:
MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares of its common stock. While the press release does not say what...
Published:
Last Updated:
Medarex Inc. (NASDAQ: MEDX) Saw shares plummet in pre-market trading. Pfizer Inc. (NYSE: PFE) has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a...
Published:
Last Updated:
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in...
Published:
Companies, even really big ones with hundreds of thousands of employees, can only fire so many people. At some point the core functions like accounting and marketing need enough personnel to keep...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) was printing money during the Covid pandemic. Still, those days are way in the rearview mirror as investors not only see shrinking sales but also see the potential for a...
Published:
Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV and in little video clips online. Reuters.com appears to have one of the ads on every...
Published:
On Mad Money last night, Jim Cramer said Pfizer (PFE) should consider buying Allergan (AGN). Cramer thinks this is a smart play similar to Johnson & Johnson acquisition of Mentor Corporation...
Published:
National City Corporation (NCC) Raising money and big dilution. Falls to $5.90 from 52-week high of $38.32. Pfizer (PFE) Concerns about big pharma results. Drifts off to $20.13. $27.73. Aladdin...
Published:
Pfizer (PFE) reports on Friday, and just liketearing off a band-aid, investors are hoping the earnings release tobe quick, and relatively painless. Nobody’s expecting anythingspectacular on...
Published:
Last Updated: